Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1964 1
1967 1
1970 2
1972 1
1977 2
1982 1
1983 1
1984 1
1985 1
1987 1
1988 1
1989 1
1990 2
1991 3
1992 7
1993 5
1994 4
1995 8
1996 12
1997 6
1998 6
1999 3
2000 6
2001 3
2002 5
2003 7
2004 16
2005 17
2006 10
2007 11
2008 20
2009 21
2010 15
2011 18
2012 23
2013 19
2014 18
2015 17
2016 14
2017 9
2018 18
2019 12
2020 19
2021 21
2022 15
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

372 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
The rise of affectivism.
Dukes D, Abrams K, Adolphs R, Ahmed ME, Beatty A, Berridge KC, Broomhall S, Brosch T, Campos JJ, Clay Z, Clément F, Cunningham WA, Damasio A, Damasio H, D'Arms J, Davidson JW, de Gelder B, Deonna J, de Sousa R, Ekman P, Ellsworth PC, Fehr E, Fischer A, Foolen A, Frevert U, Grandjean D, Gratch J, Greenberg L, Greenspan P, Gross JJ, Halperin E, Kappas A, Keltner D, Knutson B, Konstan D, Kret ME, LeDoux JE, Lerner JS, Levenson RW, Loewenstein G, Manstead ASR, Maroney TA, Moors A, Niedenthal P, Parkinson B, Pavlidis I, Pelachaud C, Pollak SD, Pourtois G, Roettger-Roessler B, Russell JA, Sauter D, Scarantino A, Scherer KR, Stearns P, Stets JE, Tappolet C, Teroni F, Tsai J, Turner J, Reekum CV, Vuilleumier P, Wharton T, Sander D. Dukes D, et al. Among authors: sander d. Nat Hum Behav. 2021 Jul;5(7):816-820. doi: 10.1038/s41562-021-01130-8. Nat Hum Behav. 2021. PMID: 34112980 Free PMC article.
Levels of valence.
Shuman V, Sander D, Scherer KR. Shuman V, et al. Among authors: sander d. Front Psychol. 2013 May 13;4:261. doi: 10.3389/fpsyg.2013.00261. eCollection 2013. Front Psychol. 2013. PMID: 23717292 Free PMC article.
The structured ambulatory post-stroke care program for outpatient aftercare in patients with ischaemic stroke in Germany (SANO): an open-label, cluster-randomised controlled trial.
Schwarzbach CJ, Eichner FA, Rücker V, Hofmann AL, Keller M, Audebert HJ, von Bandemer S, Engelter ST, Geis D, Gröschel K, Haeusler KG, Hamann GF, Meisel A, Sander D, Schutzmeier M, Veltkamp R, Heuschmann PU, Grau AJ; SANO study group. Schwarzbach CJ, et al. Among authors: sander d. Lancet Neurol. 2023 Sep;22(9):787-799. doi: 10.1016/S1474-4422(23)00216-8. Epub 2023 Jul 14. Lancet Neurol. 2023. PMID: 37459876 Clinical Trial.
The resilience framework as a strategy to combat stress-related disorders.
Kalisch R, Baker DG, Basten U, Boks MP, Bonanno GA, Brummelman E, Chmitorz A, Fernàndez G, Fiebach CJ, Galatzer-Levy I, Geuze E, Groppa S, Helmreich I, Hendler T, Hermans EJ, Jovanovic T, Kubiak T, Lieb K, Lutz B, Müller MB, Murray RJ, Nievergelt CM, Reif A, Roelofs K, Rutten BPF, Sander D, Schick A, Tüscher O, Diest IV, Harmelen AV, Veer IM, Vermetten E, Vinkers CH, Wager TD, Walter H, Wessa M, Wibral M, Kleim B. Kalisch R, et al. Among authors: sander d. Nat Hum Behav. 2017 Nov;1(11):784-790. doi: 10.1038/s41562-017-0200-8. Epub 2017 Oct 16. Nat Hum Behav. 2017. PMID: 31024125 Review. No abstract available.
Emotions in attacker-defender conflicts.
Cernadas Curotto P, Halperin E, Sander D, Klimecki O. Cernadas Curotto P, et al. Among authors: sander d. Behav Brain Sci. 2019 Aug 13;42:e120. doi: 10.1017/S0140525X19000918. Behav Brain Sci. 2019. PMID: 31407990
372 results